dichlorotetrakis(dimethyl sulfoxide)ruthenium ii has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giraldi, T; Mestroni, G; Sava, G; Zassinovich, G; Zorzet, S | 1 |
| Giraldi, T; Mestroni, G; Sava, G; Zassinovich, G | 1 |
2 other study(ies) available for dichlorotetrakis(dimethyl sulfoxide)ruthenium ii and Experimental Neoplasms
| Article | Year |
|---|---|
Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms.
Topics: Animals; Antineoplastic Agents; Blood Cell Count; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Ruthenium | 1984 |
Antitumor effects of rhodium(I), iridium(I) and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents; Cisplatin; Iridium; Lethal Dose 50; Lung Neoplasms; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Organometallic Compounds; Rhodium; Ruthenium | 1983 |